Trials / Completed
CompletedNCT04582175
Comparison Between Two Revascularization Strategies in MVD Patients With Uncomplicated ST-elevation MI
A Retrospective, One Center Comparison of Outcomes Between Complete Revascularization by PCI at the Time of PPCI or During the Index Hospital Admission in One Hundred MVD Patients With ST-elevation MI Uncomplicated by Cardiogenic Shock
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University of Oradea · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
The study aimed to compare major adverse cardiac and cerebrovascular events(MACCE) and mortality at one year between two strategies: complete revascularization including non-culprit lesions percutaneous coronary intervention(PCI) during primary PCI(PPCI) versus complete revascularisation during the same hospital admission in multi-vascular coronary artery disease(MVD) patients presenting with ST-elevation myocardial infarction(STEMI) uncomplicated by cardiogenic shock.
Detailed description
Complete revascularisation in MVD patients with STEMI uncomplicated by cardiogenic shock has been shown to improve outcomes, however the optimal timing of treatment of the non-culprit lesions is not known. The 2018 ESC/EACTS Guidelines on myocardial revascularization states that "routine revascularization of non-IRA (infarct related artery) lesions should be considered in patients with multivessel disease before hospital discharge". Our trial showed that among the fore mentioned patients there was no difference regarding outcomes when using a strategy of complete revascularization with non-culprit lesions PCI during PPCI or during the same hospital admission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | angioplasty | angioplasty of all non-culprit lesions |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-05
- First posted
- 2020-10-09
- Last updated
- 2020-10-09
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04582175. Inclusion in this directory is not an endorsement.